|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Drugmakers, Including GlaxoSmithKline (GSK) & Pfizer Inc. (PFE), Jockey to Buy Turkey's Mustafa Nevzat Ilac Sanayi
3/16/2012 7:41:44 AM
GlaxoSmithKline (Other OTC: GLAXF.PK - news) and rivals including Pfizer are preparing second-round bids for Turkey's Mustafa Nevzat Ilac Sanayi, a maker of injectable generic drugs, that may be worth some $800 million, four people familiar with the process said. The keen interest in the Istanbul-based business, also known as MN Pharmaceuticals, underscores the race by Western drugmakers to expand in emerging markets, where sales are growing much faster than in Europe and the United States. The family owners of MN Pharmaceuticals have hired Bank of America Merrill Lynch as adviser. Two sources said the owners would prefer to sell a minority stake, if the price was high enough, but that Western firms would like full control.
|
|
|
|
|
|
|
|
|
|
|